INSP icon

Inspire Medical Systems

185.61 USD
-1.54
0.82%
At close Feb 14, 4:00 PM EST
After hours
185.61
+0.00
0.00%
1 day
-0.82%
5 days
2.20%
1 month
9.19%
3 months
7.33%
6 months
-2.43%
Year to date
-1.89%
1 year
-3.28%
5 years
128.67%
10 years
643.03%
 

About: Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.

Employees: 1,246

0
Funds holding %
of 6,831 funds
0
Analysts bullish %
of 9 analysts

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

500% more funds holding in top 10

Funds holding in top 10: 1 [Q2] → 6 (+5) [Q3]

63% more capital invested

Capital invested by funds: $4.38B [Q2] → $7.13B (+$2.75B) [Q3]

42% more first-time investments, than exits

New positions opened: 78 | Existing positions closed: 55

6% more funds holding

Funds holding: 323 [Q2] → 342 (+19) [Q3]

3.26% more ownership

Funds ownership: 110.11% [Q2] → 113.36% (+3.26%) [Q3]

3% more repeat investments, than reductions

Existing positions increased: 113 | Existing positions reduced: 110

9% less call options, than puts

Call options by funds: $121M | Put options by funds: $132M

Research analyst outlook

9 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
$190
2%
upside
Avg. target
$230
24%
upside
High target
$260
40%
upside

9 analyst ratings

positive
78%
neutral
22%
negative
0%
Truist Securities
Richard Newitter
74% 1-year accuracy
31 / 42 met price target
27%upside
$235
Buy
Maintained
11 Feb 2025
RBC Capital
Shagun Singh
61% 1-year accuracy
41 / 67 met price target
40%upside
$260
Outperform
Reiterated
11 Feb 2025
Baird
Mike Polark
73% 1-year accuracy
8 / 11 met price target
34%upside
$248
Outperform
Maintained
11 Feb 2025
Wells Fargo
Larry Biegelsen
63% 1-year accuracy
30 / 48 met price target
5%upside
$195
Equal-Weight
Maintained
11 Feb 2025
Morgan Stanley
Kallum Titchmarsh
67% 1-year accuracy
2 / 3 met price target
19%upside
$220
Overweight
Maintained
11 Feb 2025

Financial journalist opinion

Based on 11 articles about INSP published over the past 30 days

Positive
Zacks Investment Research
3 days ago
How Much Upside is Left in Inspire (INSP)? Wall Street Analysts Think 25.88%
The consensus price target hints at a 25.9% upside potential for Inspire (INSP). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
How Much Upside is Left in Inspire (INSP)? Wall Street Analysts Think 25.88%
Positive
Zacks Investment Research
5 days ago
INSP Stock Declines Despite Q4 Earnings Beat, Gross Margin Contracts
Inspire Medical's both geographic segments witness strong revenue growth on the back of solid product demand in the fourth quarter.
INSP Stock Declines Despite Q4 Earnings Beat, Gross Margin Contracts
Neutral
Seeking Alpha
5 days ago
Inspire Medical Systems, Inc. (INSP) Q4 2024 Earnings Call Transcript
Inspire Medical Systems, Inc. (NYSE:INSP ) Q4 2024 Earnings Conference Call February 10, 2025 5:00 PM ET Company Participants Ezgi Yagci - Vice President of Investor Relations Tim Herbert - President & Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Travis Steed - Bank of America Securities Danielle Antalffy - UBS Robbie Marcus - JPMorgan Chris Pasquale - Nephron Research Anthony Petrone - Mizuho Financial Group Richard Newitter - Truist Securities David Rescott - Baird Adam Maeder - Piper Sandler Larry Biegelsen - Wells Fargo Shagun Singh - RBC Capital Markets Brett Fishbin - KeyBanc Capital Markets Jon Block - Stifel Michael Polark - Wolfe Research Mike Kratky - Leerink Partners Suraj Kalia - Oppenheimer & Co. Operator Good afternoon. My name is Dilem [ph] and I'll be your conference operator today.
Inspire Medical Systems, Inc. (INSP) Q4 2024 Earnings Call Transcript
Positive
The Motley Fool
6 days ago
Inspire Medical's Earnings Surge in Q4
Inspire Medical Systems (INSP -0.64%), known for its innovative devices that use neurostimulation to treat sleep apnea, announced impressive fourth-quarter results on Feb. 10. Earnings per share (EPS) came in at $1.15, well ahead of the $0.73 consensus estimate.
Inspire Medical's Earnings Surge in Q4
Positive
Zacks Investment Research
6 days ago
Inspire (INSP) Reports Q4 Earnings: What Key Metrics Have to Say
Although the revenue and EPS for Inspire (INSP) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Inspire (INSP) Reports Q4 Earnings: What Key Metrics Have to Say
Positive
Zacks Investment Research
6 days ago
Inspire Medical Systems (INSP) Q4 Earnings and Revenues Surpass Estimates
Inspire Medical Systems (INSP) came out with quarterly earnings of $1.15 per share, beating the Zacks Consensus Estimate of $0.74 per share. This compares to earnings of $0.49 per share a year ago.
Inspire Medical Systems (INSP) Q4 Earnings and Revenues Surpass Estimates
Neutral
GlobeNewsWire
6 days ago
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Outlook
Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024 Inspire Reports Year-over-Year Revenue Growth of 25% and Earnings per Share Growth of 135% for the Fourth Quarter 2024
Inspire Medical Systems, Inc. Announces Fourth Quarter and Full Year 2024 Financial Results and Updates 2025 Outlook
Positive
Zacks Investment Research
1 week ago
Countdown to Inspire (INSP) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Beyond analysts' top -and-bottom-line estimates for Inspire (INSP), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended December 2024.
Countdown to Inspire (INSP) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Positive
Zacks Investment Research
1 week ago
Inspire Medical Systems (INSP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Inspire (INSP) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Inspire Medical Systems (INSP) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Positive
Zacks Investment Research
1 week ago
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Charts implemented using Lightweight Charts™